[DNLI] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
12-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 319.20%
YoY- 438.76%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 10,283 12,514 316,815 4,672 125,676 145,149 0 -
PBT -98,684 -75,836 245,708 -53,950 77,533 -22,887 -19,354 31.17%
Tax -6 -575 823 75 -2,379 -807 90 -
NP -98,678 -75,261 244,885 -54,025 77,533 -22,887 -19,354 31.17%
Tax Rate - - -0.33% - 3.07% - - -
Total Cost 108,961 87,775 71,930 58,697 48,143 168,036 19,354 33.36%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -959.62 -601.41 77.30 -1,156.36 61.69 -15.77 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.74 -0.62 2.04 -0.57 0.82 -0.74 -2.15 -16.27%
EPS Diluted -0.74 -0.62 1.91 -0.56 0.79 -0.74 -2.15 -16.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.